Myriad Genetics reported $1.58B in Market Capitalization this October of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Accelerate Diagnostics AXDX:US 0.08B 0.02B
Agilent A:US $ 35.48B 4.24B
Becton, Dickinson and BDX:US $ 70.31B 5.52B
Bio Rad Laboratories BIO:US $ 14.7B 2.28B
Biocept BIOC:US $ 0.04B 0.02B
Bruker BRKR:US $ 9.37B 0.33B
Danaher DHR:US $ 184.33B 25.66B
Exact Sciences EXAS:US $ 6.93B 5.34B
Fluidigm FLDM:US $ 0.12B 0.15B
Hologic HOLX:US $ 17.28B 1.92B
Illumina ILMN:US $ 28.96B 25.92B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Mettler Toledo International MTD:US $ 25.86B 5.29B
Myriad Genetics MYGN:US $ 1.46B 0.55B
Nanostring Technologies NSTG:US $ 0.59B 1.01B
Orasure Technologies OSUR:US $ 0.2B 0.3B
Pacific Biosciences Of California PACB:US $ 0.99B 1.05B
Perkinelmer PKI:US $ 17.94B 4.07B
Quest Diagnostics DGX:US $ 15.56B 0.56B
Quidel QDEL:US $ 6.5B 1.8B
Repligen RGEN:US $ 9B 1.4B
Thermo Fisher Scientific TMO:US $ 212.67B 18.53B
Veracyte VCYT:US $ 1.42B 0.54B
Waters WAT:US $ 19.94B 1.19B